<SEC-DOCUMENT>0000950170-21-002018.txt : 20211005
<SEC-HEADER>0000950170-21-002018.hdr.sgml : 20211005
<ACCEPTANCE-DATETIME>20211005160538
ACCESSION NUMBER:		0000950170-21-002018
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210930
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211005
DATE AS OF CHANGE:		20211005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Calyxt, Inc.
		CENTRAL INDEX KEY:			0001705843
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				271967997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38161
		FILM NUMBER:		211306659

	BUSINESS ADDRESS:	
		STREET 1:		2800 MOUNT RIDGE ROAD
		CITY:			ROSEVILLE
		STATE:			MN
		ZIP:			55113
		BUSINESS PHONE:		(651) 683-2807

	MAIL ADDRESS:	
		STREET 1:		2800 MOUNT RIDGE ROAD
		CITY:			ROSEVILLE
		STATE:			MN
		ZIP:			55113
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>clxt-20210930.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2021-10-05T13:17:05.0600+00:00 --><!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:clxt="http://www.calyxt.com/20210930" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_8d41b2b2-bed9-4cb8-8e45-27e369e42d76" name="dei:AmendmentFlag" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6">false</ix:nonNumeric><ix:nonNumeric id="F_2544e6e0-d26b-4df7-a42d-2edf3112b300" name="dei:EntityCentralIndexKey" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6">0001705843</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="clxt-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001705843</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.500pt solid;text-align:center;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Washington, D.C. 20549</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.500pt solid;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:18.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_08d05f39-14de-48c7-b8fd-d5049c35102f" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">8-K</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.500pt solid;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Pursuant to Section 13 or 15(d)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">of the Securities Exchange Act of 1934</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Date of Report: (Date of earliest event reported): October 5, 2021 (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_958da7ef-3689-4264-957d-cf31d0283aec" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">)</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.500pt solid;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:18.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3bfac569-f054-4716-afea-d24872ed4f5d" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">Calyxt, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Exact name of registrant as specified in its charter)</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.500pt solid;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.526%;"></td>
    <td style="width:1.677%;"></td>
    <td style="width:31.56%;"></td>
    <td style="width:1.677%;"></td>
    <td style="width:31.56%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_66746165-a498-40fd-a266-72bc67d1d4aa" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_12afb1e9-f119-42be-bb64-14e563e33a6d" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">001-38161</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2e45622d-f02d-4280-9f9a-4e3531bbdad9" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">27-1967997</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(State or other jurisdiction</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">of incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Commission</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(IRS Employer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4edec223-8129-4362-830b-d07ed2686b23" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2800 Mount Ridge Road</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9ac55e2b-72d3-41e7-a373-1f17440fdd54" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Roseville</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_77bee25f-da9c-413e-b0c5-f3ff5d1611b8" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">MN</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c9092474-3a29-41c4-8a11-c7251cfa9582" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">55113-1127</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Address and zip code of principal executive offices)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_03144b56-fc37-4cf4-a652-0bf686c75ed9" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(651)</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_656fa57f-4ea7-4099-806e-2cabbd490c04" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">683-2807</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Registrant&#x2019;s telephone number, including area code)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Not Applicable</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Former name or former address, if changed since last report)</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.500pt solid;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.462%;"></td>
    <td style="width:96.538%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e088d97b-3f54-4c86-bb13-e7371789b78a" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.665%;"></td>
    <td style="width:96.335%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6dc712e2-e00c-4e6e-9ee1-30655c2971f4" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.462%;"></td>
    <td style="width:96.538%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af10d99f-00c0-4c50-8d7d-65d114810627" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.462%;"></td>
    <td style="width:96.538%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bed1ae3d-f0b0-4906-a0d2-ea4116e9db0b" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.769%;"></td>
    <td style="width:3.536%;"></td>
    <td style="width:31.378%;"></td>
    <td style="width:3.237%;"></td>
    <td style="width:31.079%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:1.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:1.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:1.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Trading Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:1.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:1.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Name of exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b4569e1b-e5cb-4c2d-90fb-e8e05435cfb7" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ed401073-f5ac-4a38-992a-b4c502018aed" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CLXT</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_041f4a50-b053-43e4-9333-d29140b5974c" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">The NASDAQ Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:2.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Emerging growth company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3f090adf-26c5-4d56-9a4a-65afc40a7135" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:2.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cf01d068-51b2-4e5b-8b7d-4d54dfe41b92" contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <hr style="page-break-after:always;" />
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:10.759%;"></td>
    <td style="width:89.241%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2.02.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Results of Operations and Financial Condition</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On October 5, 2021, Calyxt, Inc. (&#x201c;Calyxt&#x201d;) issued a press release, the full text of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:10.759%;"></td>
    <td style="width:89.241%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 8.01.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Other Events.</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On October 5, 2021, Calyxt issued the press release referred to in Item 2.02 above, which is incorporated by reference into this Item 8.01.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Calyxt is also providing in this Current Report on Form 8-K the following risk factor, which supplements the risk factors disclosed in Item 1A of its Annual Report on Form 10-K for the fiscal year ended December 31, 2020:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our operational and financial success depends on our ability to successfully implement our strategic initiative to provide synthetic biology solutions for an expanded group of end markets, which is subject to a variety of risks and uncertainties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our inception, we have deployed our technology platform toward delivering plant-based innovations and solutions, primarily to the agriculture end market. In October 2021, we announced a strategic initiative that will focus Calyxt on engineering plant-based synthetic biology solutions to meet the demand-driven needs of a diversified base of potential customers across an expanded group of end markets, including the nutraceutical, cosmeceutical, personal care, pharmaceutical, advanced materials, and chemical industries, in addition to the agriculture end market.  This expanded and diversified focus will place significant demands on our management, will require adaptations to our operational infrastructure, and necessitate incremental capital expenditures. If we fail to effectively and efficiently manage and implement the strategic initiative, our business, financial condition and results of operations would be adversely impacted. We would face similar adverse impacts if we are unable to differentiate Calyxt&#x2019;s offerings and capabilities from competitors in the synthetic biology industry, who may have competitive advantages over us, or if we are otherwise not successful in marketing our offerings and capabilities to new target customers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, to the extent we face technological and other challenges, including unanticipated costs, in leveraging our PlantSpring platform for the development of compounds intended to be produced in the BioFactory manufacturing facility, adapting our technology platform for specific customer-driven molecule needs, or scaling production, our business, financial condition and results of operations would be adversely impacted. The artificial intelligence and machine learning capabilities that Calyxt is developing for our PlantSpring platform remain in the early stages of development, and their implementation and effectiveness could be adversely affected by flawed algorithms, insufficient datasets, or errors resulting from human intervention.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, because of the novelty and complexity of our PlantSpring platform and BioFactory, achieving broad commercial success may require that we overcome potential customer skepticism regarding our capabilities, particularly in light of the historical challenges of scaling production in the field of synthetic biology.  If we do not achieve the technical specifications required by our customers or successfully manage new product development processes, or if development work is not performed according to schedule, then our revenue growth from new pipeline products may be prevented or delayed, and our business and operating results may be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:10.78%;"></td>
    <td style="width:89.22%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9.01.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Financial Statements and Exhibits.</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">d. Exhibits</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9.001%;"></td>
    <td style="width:3.004%;"></td>
    <td style="width:87.994%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid rgba(0,0,0,1);text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Description</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="clxt-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">99.1</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="clxt-ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Press Release dated October 5, 2021</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, Calyxt, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br />Dated: October 5, 2021</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.059%;"></td>
    <td style="width:7.006%;"></td>
    <td style="width:34.485%;"></td>
    <td style="width:10.45%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CALYXT, INC</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;padding-bottom:0.021in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;padding-bottom:0.021in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:1.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Michael A. Carr</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;padding-bottom:0.021in;border-bottom:1.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Michael A. Carr</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President and Chief Executive Officer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>clxt-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(128,128,128,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Calibri;"> </font><img src="img232900384_0.jpg" alt="img232900384_0.jpg" style="width:314px;height:56px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:14.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(118,146,60,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:Calibri;font-style:italic;">Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded Group of End Markets and Diversified Base of Customers</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;font-style:italic;">-Proprietary PlantSpring</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:7.37pt;font-family:Calibri;font-style:italic;">TM</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;font-style:italic;"> technology platform expanded and achieves rapid development of plant-based biomolecules-</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;font-style:italic;">-PlantSpring leverages artificial intelligence and machine learning-</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;font-style:italic;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;font-style:italic;">-First pilot BioFactory&#153; manufacturing facility is being developed to work in concert with PlantSpring for producing plant biomolecules at scale and sustainably-</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;font-style:italic;">-Continues current technology licensing and product development activities as synergistic components of the expanded business model-</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;font-style:italic;">-Hosts conference call and webcast today at 4:30 p.m. ET-</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">Roseville, MN &#x2013; Tuesday, October 5, 2021 &#x2013;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Calyxt, Inc.</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the Company on engineering synthetic biology solutions for a diversified base of customers across an expanded group of end markets including the nutraceutical, cosmeceutical, pharmaceutical, advanced materials, and chemical industries.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Central to the strategy is the integration of the Company&#x2019;s proprietary technology platform, PlantSpring, with its newly commissioned pilot bioreactor, the BioFactory, which together will enable Calyxt to rapidly prototype and produce complex plant-derived compounds without the need for outdoor cropping systems. The Company estimates that, aided by machine learning and artificial intelligence, it will be able to take a customer&#x2019;s molecule need through Calyxt&#x2019;s design, engineering, verification, and pilot-level production process within a 36-month period, with commercial scale production to commence thereafter. The final output, based upon the engineering of plant metabolism to mass produce plant-based compounds, is designed to provide customers across industries a safe and more sustainable supply of these compounds for use in a myriad of products and manufacturing processes.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">&#x201c;By leveraging our proprietary PlantSpring technology platform with our newly commissioned pilot bioreactor, the BioFactory, Calyxt has the pieces in place to advance plant-based synthetic biology solutions for important target customers and end markets to help those groups produce more sustainable products toward meeting their corporate sustainability targets,&#x201d; said Michael A. Carr, President and Chief Executive Officer of Calyxt. &#x201c;These new potential customers include large corporations within such industries as nutraceuticals, cosmeceuticals, personal care, and pharmaceuticals, as well as companies that manufacture advanced materials and chemicals.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Mr. Carr added: &#x201c;Through our engineering of the metabolism of plants, Calyxt unlocks plants&#x2019; ability to exponentially multiply production of finite biomolecules into large quantities, enabled within a bioreactor that does not use fermentation or farmland. As a result, Calyxt offers customers the opportunity to target a broad range of plant biomolecules and applications produced through a highly sustainable process, and within a highly efficient timeframe aided by our emerging machine learning and artificial intelligence toolkit. Our efforts are already underway to market our expanded offerings to new target customers.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;font-style:italic;">PlantSpring Technology Platform: Built on a Decade of Engineering Experience</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The Company&#x2019;s technology platform, newly named PlantSpring, has been built on Calyxt&#x2019;s experience of more than a decade engineering plant metabolism, its proprietary systems, its tools and technologies, and an expanding set of artificial intelligence and machine learning capabilities. This licensable platform has powered the Calyxt innovation engine, previously focused primarily on the agriculture end market. Together with the BioFactory, this platform opens a wide array of new end markets to Calyxt.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The platform delivers innovation through an efficient process from laboratory to pilot, which includes identification of breakthrough molecules based on customer needs and design strategies to reprogram host cells; engineering of plant cell metabolism to optimally produce targeted molecules; and production of target molecules at pilot scale. Calyxt has developed early-stage artificial intelligence and machine learning capabilities in PlantSpring, which enable learning and adaptation from knowledge gained from past activity and can be combined with predictive analytics to rapidly prototype and provide feedback, accelerating the time from design to pilot and de-risking the commercial scale-up phase. As a result, Calyxt believes it can develop engineered biomolecules in plants for customers at faster speeds than its competitors in the synthetic biology industry. Calyxt expects to continue to develop its artificial intelligence and machine learning capabilities end-to-end across the PlantSpring platform and the BioFactory and anticipates this augmentation to continue to drive down development timeframes.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">&#x201c;Calyxt&#x2019;s scientists are experts at engineering plant metabolism, which includes enabling the plant cells to produce more or less of certain chemistries, or novel chemistries, that may be unique to plants. The scientific team has demonstrated this capability many times over across multiple plant species,&#x201d; said Travis Frey, Ph.D., Chief Technology Officer of Calyxt. &#x201c;We leverage our PlantSpring technology platform as the engine that drives Calyxt&#x2019;s R&amp;D capabilities. It combines our company&#x2019;s decade of technology, know-how and intellectual property and enables us to engineer important plant biomolecules, often found at scarcity in nature, and to eventually produce these biomolecules at scale for our customers.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;font-style:italic;">The BioFactory: Leveraging the Power of Plants to Efficiently and Sustainably Manufacture at Scale</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;font-style:italic;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The output from the PlantSpring platform integrates seamlessly with the Company&#x2019;s newly commissioned BioFactory.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The BioFactory is the culmination of the work of Calyxt&#x2019;s researchers and will enable the Company to expand its production methods from solely outdoor agriculture systems to also include controlled environment, bioreactor-based production systems.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">In a world seeking to evolve to more sustainable solutions, the Company believes that plants are uniquely capable of producing many compounds that cannot be produced through other currently available means, including microbial fermentation. Calyxt estimates that more than 80 percent of all known natural compounds are able to be produced by plants. These known natural compounds comprise over 200,000</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">chemistries today, and the Company believes plants have the potential to access many of the nearly one million estimated chemistries not yet discovered.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The BioFactory harnesses the potential of plant cells in a matrixed structure, combined with nutrients and media for its production, and leverages multiple cell types. The matrix structures enable controlled replication and processing of molecules, with the replication accelerating exponentially over time.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The BioFactory produces these plant-based molecules within a synthetic biology bioreactor. Calyxt has produced multiple proof of concept biomolecules in its laboratories. The initial pilot BioFactory will operate from Calyxt&#x2019;s headquarters in Roseville, Minnesota, and is currently expected to be online by the end of 2021. The Company plans to work with infrastructure partners to build capabilities to produce at larger scales to meet anticipated customer demand. The transition from pilot to commercialization is expected to be facilitated through third-party contract manufacturers, who can provide at-scale production in support of our asset-light strategy. The Company anticipates that its customer demand-driven focus and use of third-party contractors for at-scale manufacturing addresses key uncertainties of anticipating market demand and the cost constraints of maintaining at-scale production capacity.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Significantly, Calyxt&#x2019;s BioFactory manufacturing process relies on plant cell matrices for production, and its initial growth rates using this system have presented a strong productivity curve. Evaluated in grams per day over a 30-day period, these initial results suggest our plant cells grow more than five times faster than other plant-based systems, as reported in the scientific literature to date.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The Company&#x2019;s manufacturing approach notably does not use fermentation. As a result, Calyxt&#x2019;s process at scale is expected to be simpler, create less water waste and disposal, and allow customers to stack multiple molecules from plants, even potentially turning by-products into useful products.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">&#x201c;The scaled production of these biomolecules through our BioFactory will be vital for our customers because it will provide them with more sustainable-sourced materials for their own manufacturing processes,&#x201d; said Dr. Frey. &#x201c;Furthermore, we believe the BioFactory has the potential to be one of the most productive and sustainable plant-based processes across industries because of its production methodology. Based on our initial test results we expect to produce compounds at higher yields and throughputs on a per-unit basis, which is one of the reasons we believe the BioFactory can be scaled. Because it does not use fermentation, we expect fewer of the sustainability challenges associated with other indoor systems, including potentially lower levels of off-gasses, reduced water demands and lower energy requirements.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;font-style:italic;">Technology Licensing and Partnered Agricultural Development</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;font-style:italic;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">As a synergistic component of its expanded strategy, the Company expects to continue to license its technology and develop products for agricultural customers based on their needs.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">With respect to technology licensing, this activity spans Calyxt&#x2019;s vast intellectual property library including multiple gene editing platforms, plant breeding, and other capabilities as well as the licensing of historically developed product candidates, including improved digestibility alfalfa licensed to S&amp;W Seeds, high oleic, low linolenic soybeans, and product candidates derived from its hemp advancements.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">As demonstrated by the recent announcement of a new product to be developed for a partner in soybeans, Calyxt will continue to opportunistically develop products for customers focused on traditional</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">outdoor agriculture. To ensure appropriate resourcing of the opportunities, Calyxt has developed a set of criteria by which all opportunities are vetted, which include the size of the overall opportunity, the nature of the product to be developed, and the amount of cash to be received both upfront and over time.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;font-style:italic;">Recent Corporate &amp; Financial Highlights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Appointed Michael A. Carr as its President, Chief Executive Officer, and member of its Board of Directors effective July 27, 2021. Mr. Carr brings more than 20 years of business, financial and operational leadership experience to Calyxt and will focus on advancing and monetizing Calyxt&#x2019;s technologies. Prior to joining Calyxt, he most recently served as Vice President of M&amp;A, Strategy, and Innovation at Darling Ingredients, Inc.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Successfully transformed the hemp genome and produced &#x201c;pollen-proof&#x201d; (seedless) hemp with its triploid breeding technology. Combined, Calyxt&#x2019;s hemp advancements offer significant advantages in innovation, crop management, and harvest potential. In our partner-driven model, we can now develop and deliver hemp products tailored for their needs across plant-based proteins and oils, advance materials, fiber, cosmeceuticals, nutraceuticals, and others.</font></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Calibri;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">On September 21, 2021, launched a $50 million at-the-market (ATM) share issuance program. As of today, the Company has not sold any shares pursuant to the program. </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Entered into a research collaboration with a leading global food ingredient manufacturer based in Asia to develop an improved soybean capable of producing an oil as a sustainable commercial alternative to palm oil. As part of the research collaboration, Calyxt will receive cash payments in each of the two years of its term. This collaboration agreement also includes a commercial option for the global food ingredient manufacturer. </font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">As of September 30, 2021, Calyxt had cash, cash equivalents, and restricted cash of $14.9 million.  This represents cash usage of approximately $3.6 million in the third quarter of 2021. This strong cash performance was driven by collections from the sale of grain to Archer Daniels Midland (ADM), continued declines in our working capital investment associated with the wind down of that grain sales activity, and strong operating expense management.</font></div></div>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">As of today, Calyxt has nearly completed the sale of its inventory of 2020 grain to ADM. This series of transactions, which began in the third quarter of 2020, has generated $35.7 million in total cash proceeds. The Company remains on track to complete these sales by the end of the year.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">Conference Call and Webcast</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">President and Chief Executive Officer Michael A. Carr, Chief Financial Officer Bill Koschak, and Chief Technology Officer Dr. Travis Frey will host a conference call and webcast discussing Calyxt's business update, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of Calyxt's website, www.calyxt.com.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">To access the call, please use the following information:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Date: Tuesday, October 5, 2021</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Time: 4:30 p.m. ET, 1:30 p.m. PT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Toll Free dial-in number: +1 888-317-6003</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Toll/International dial-in number: +1 412-317-6061</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Conference ID: 9817980</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Participants should call the conference telephone number 5 to 10 minutes prior to the start time. An operator will register participants&#x2019; names and organizations. The conference call will also be broadcast live and available for replay via the investor relations section of the company's website, www.calyxt.com. A replay of the webcast will be available for 30 days following the event.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Toll Free Replay Number: +1-877-344-7529</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">International Replay Number: +1-412-317-0088</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Replay ID: 10160509</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">About Calyxt</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring&#153; technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt&#x2019;s diversified offerings are delivered through its proprietary BioFactory&#153; manufacturing process. For more information, visit </font><font><font style="background-color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">www.calyxt.com</font></font><font style="background-color:rgba(255,255,255,1);color:rgba(49,49,53,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">PlantSpring, BioFactory and the Calyxt logo are trademarks of Calyxt, Inc.  Any other trademarks belong to their respective owners.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">Forward-Looking Statements</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">This communication contains &#x201c;forward-looking statements&#x201d; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as &#x201c;anticipates,&#x201d; &#x201c;believes,&#x201d; &#x201c;continue,&#x201d; &#x201c;estimates,&#x201d; &#x201c;expects,&#x201d; &#x201c;intends,&#x201d; &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;plans,&#x201d; &#x201c;predicts,&#x201d; &#x201c;projects,&#x201d; &#x201c;should,&#x201d; &#x201c;targets,&#x201d; &#x201c;will,&#x201d; or the negative of these terms and other similar terminology. Forward-looking statements in this press release include statements about our future financial performance; product pipeline and development; our business model and strategies for the development, commercialization and sales of commercial products; commercial demand for our synthetic biology solutions; the development and deployment of our PlantSpring technology platform; the ability to scale production capability for our BioFactory; flaws in artificial intelligence and machine learning (AI/ML) algorithms, insufficiency of data inputs required by such algorithms, and human error in interacting with AI/ML; potential collaborations, partnerships, customer relationships, and licensing arrangements and their contribution to our financial results, cash usage, and growth strategies; and anticipated trends in our business. These and other forward-looking statements are predictions and projections about future events and trends based on our current expectations, objectives and intentions and premised on current assumptions. Our actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: the severity and duration of the evolving COVID-19 pandemic and the resulting impact on macro-economic conditions; the impact of increased competition, including competition from a broader array of synthetic biology companies; disruptions at our key facilities, including disruptions impacting our BioFactory; changes in customer preferences and market acceptance of our products; changes in market consensus</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">as to what attributes are required for a product to be considered &#x201c;sustainable,&#x201d; competition for collaboration partners and licensees and the successful execution of collaborations and licensing agreements; the impact of adverse events during development, including unsuccessful pilot production of molecules or field trials; the impact of improper handling of our product candidates during development; failures by third-party contractors; inaccurate demand forecasting; the effectiveness of commercialization efforts by commercial partners or licensees; disruptions to supply chains, including raw material inputs for our BioFactory; the impact of changes or increases in oversight and regulation; disputes or challenges regarding intellectual property; proliferation and continuous evolution of new technologies; management changes; dislocations in the capital markets; and other important factors discussed under the caption entitled &#x201c;Risk Factors&#x201d; in our Annual Report on Form 10-K and subsequent filings on Form 10-Q or 8-K with the U.S. Securities and Exchange Commission. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">The financial information as of, and for the quarter ended, September 30, 2021, included in this press release is preliminary and is based on the latest estimated unaudited management accounts. Such information is subject to the completion of management&#x2019;s reviews and other financial closing processes and potential adjustments. Accordingly, the Company&#x2019;s actual cash, cash equivalents and restricted cash position as of September 30, 2021, and cash usage for the quarter may differ materially from the preliminary estimated data presented in this press release.  The information contained in this press release has not been, and is not based on information that has been, audited or reviewed by Calyxt&#x2019;s independent auditor.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">Contacts:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:49.994%;"></td>
    <td style="width:50.006%;"></td>
   </tr>
   <tr style="height:11.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">Calyxt Media Contact:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;"> </font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">Calyxt Investor Relations Contact:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;"> </font></p></td>
   </tr>
   <tr style="height:11.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">David Rosen/Sarah Sutton/John Garabo</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Argot Partners</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">(212) 600-1902</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">media@calyxt.com</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;"> </font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Sherri Spear</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Argot Partners</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">(212) 600-1902</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font><font style="background-color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">investors@calyxt.com</font></font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p></td>
   </tr>
   <tr style="height:11.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;">Calyxt Business Development Contact:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Calibri;"> </font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p></td>
   </tr>
   <tr style="height:11.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Sarah Reiter</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">Calyxt, Inc.</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">(612) 427-7881</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">contact@calyxt.com</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">###</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img232900384_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img232900384_0.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M=B?*8L?F*'[A/X<<_P!TUYE:BZ;U5F?G&>Y,\OE=1M;='H%+117(?'A1110
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M$:N][4?6HIX-TN9QD[RZ@%+117I@%%%% !1110 4444 ? /[=D7E_&6P;/\
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M=;:FTB%D(3RWC3 5NA.Y),@=,C/6OI>&)..,>FC12)?V]O\ DD>C'_J.0_\
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M#^LLL%P6QB&4<1RY[ $X;V.>PK]%N&6OQ]M;6:^N(X+>*2XGD;:D42EF9CT
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M5ZXP>>M%XB<JE)76GSL[C/4AQQ7E7[3VC6.L_ WQ4M^5C6WMOM,,C=5E0AD
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M_)N_BCZVG_I5#7GSDJLL1*,;)Q7SW ]8TG2K;1=+M+"RA6WM+6)((8D&%1%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>clxt-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-10-05T13:17:05.4545+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOrganizationsAbstract" xlink:label="us-gaap_HealthCareOrganizationsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCareOrganizationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Care Organizations [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationsAbstract" xlink:to="us-gaap_HealthCareOrganizationsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>clxt-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-10-05T13:17:05.4240+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="clxt-20210930.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>clxt-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-10-05T13:17:05.3670+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.calyxt.com/20210930" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:clxt="http://www.calyxt.com/20210930" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clxt-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clxt-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>clxt-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clxt-20210930.xsd" xlink:type="simple"/>
    <context id="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001705843</identifier>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_8d41b2b2-bed9-4cb8-8e45-27e369e42d76">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_2544e6e0-d26b-4df7-a42d-2edf3112b300">0001705843</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_08d05f39-14de-48c7-b8fd-d5049c35102f">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_958da7ef-3689-4264-957d-cf31d0283aec">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_3bfac569-f054-4716-afea-d24872ed4f5d">Calyxt, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_66746165-a498-40fd-a266-72bc67d1d4aa">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_12afb1e9-f119-42be-bb64-14e563e33a6d">001-38161</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_2e45622d-f02d-4280-9f9a-4e3531bbdad9">27-1967997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_4edec223-8129-4362-830b-d07ed2686b23">2800 Mount Ridge Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_9ac55e2b-72d3-41e7-a373-1f17440fdd54">Roseville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_77bee25f-da9c-413e-b0c5-f3ff5d1611b8">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_c9092474-3a29-41c4-8a11-c7251cfa9582">55113-1127</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_03144b56-fc37-4cf4-a652-0bf686c75ed9">(651)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_656fa57f-4ea7-4099-806e-2cabbd490c04">683-2807</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_e088d97b-3f54-4c86-bb13-e7371789b78a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_6dc712e2-e00c-4e6e-9ee1-30655c2971f4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_af10d99f-00c0-4c50-8d7d-65d114810627">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_bed1ae3d-f0b0-4906-a0d2-ea4116e9db0b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_b4569e1b-e5cb-4c2d-90fb-e8e05435cfb7">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_ed401073-f5ac-4a38-992a-b4c502018aed">CLXT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_041f4a50-b053-43e4-9333-d29140b5974c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_3f090adf-26c5-4d56-9a4a-65afc40a7135">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6"
      id="F_cf01d068-51b2-4e5b-8b7d-4d54dfe41b92">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140644905638344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Calyxt, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001705843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLXT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1967997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2800 Mount Ridge Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Roseville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55113-1127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(651)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-2807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#V@/LS!:^CS%C;H8JH'2J=+Y6&U"MX#'$J7A\<S 1L!-5%B=.US][AZ#+(<
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ JH!%4V60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( *J 15,;:25T[@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( *J 15.97)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ JH!%4P99!N-:!   Y!   !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( *J 15.?H!OPL0(
M .(,   -              "  9T,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /T3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="clxt-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="clxt-20210930.htm">clxt-20210930.htm</File>
    <File>clxt-20210930.xsd</File>
    <File>clxt-20210930_lab.xml</File>
    <File>clxt-20210930_pre.xml</File>
    <File>clxt-ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "clxt-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "clxt-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clxt-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clxt-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clxt-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "clxt",
   "nsuri": "http://www.calyxt.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "clxt-20210930.htm",
      "contextRef": "C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "clxt-20210930.htm",
      "contextRef": "C_86938f49-cf5b-44c2-a0e5-0b5581e9e3a6",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.calyxt.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-21-002018-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-21-002018-xbrl.zip
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ME'OD:&Z>UK8I](U!O2BVZ"*[&TM&K"27,DD +J*J:.Q9 "F1PE2)VUW]$>1
M#\="E+J;7 #9..4*FDD)U,2UVYF!Q@<"%#*6:.BBC8R7VF0E7@8)< F= -Z
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M3U>Z!?A++RUV:HW0=.(NHP3[4.0B0E4S$_Q&98^S1$08%:IUMP8>7&M/;QF
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M.3SM]D(W;9/]CZHH93QI+R1^6T@#66>IU,&$=>C':EE^;R1BPN26O$HF1 >
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MRFPW#N+]G\,N\*)]$_.3E%/+YZ<=B-6IE)9/T!LD?'N0ZTR6R<OHE&Y:'AA
M*Y$T.DO&P4B*F!Q>B:C2<65?,3O;RQR'VX!9:P>*=6JFY1/4$;XC?$?XCO O
MJ LV)%Z[BZG]"7&!CQNS^=1!FYLXZK<XTYLD^:N09IV2/VWP"5)@=1S1TK,[
M>_TPXY,/?]KKC\IQ\N'_ 5!+ P04    " "J@$531U"E[Q4#  #&"0  $0
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MVD7['TJ)4N2)@6_J#7Q9,/ !A[;&H26PY;_S8"I4I)ZQJ5"76='D^$6<3-G
MM#/5D*5E *MU2]7^K!820-S^EOFEI,4O8:D6M$ W()*<+=02GX#!<YB0!3%A
M="O:W][J>E<0Q:]5T+A!'G!-<@7PL("HH)LA^OM#2^H;_D:CQAPNH='>2[/^
MN#([.#EU*!Y'Z^@.8]T@U>\&K/%I.'>E6A5$3I;:.1@?3A%KF'#<K2(5<T ?
M;#5.>'NA@;[49J[@CF5*HLAY(+SS 19"=D 8&R96FWI=J42*5T3 "O7!$[L<
MCNTE?)JD=M@'1Q,T3<W40,$M)#9P(3?P7Z I5<74R=5JZ4;B(J%@"C89*8$C
M.@>D0)/4O]XR!;'=<K?M: #0X85-8>*X,MP;^1Y^1.K6 C\HQCS5>@'(-%]X
M6+1/Y<H!%@Y2^CH00#SQ^[2Y3+8(_D.T;A5!Z<&-AS\SU%H0,J"[2W'T<+@$
M;%J("H8PN=]4W$IE:3VLH2=#P!+H-@JNN'-*SH!@,O1FH, 7".&J 9@Q]VDJ
M? EUIX0C!&NN6 *R@:BCW1('7DKGXNZF+"SNZ0#1F6' 9HC*.Y^VN$5+KY&#
MR9FWY %")K8&_+NJ ,'X1#B58 \B2^/PX,  RS7PA)SFS:!PWC"86DP\=!,.
M<2=(5T^I;YA2\VG.3I^M@_V9SD1C.P0XM:7M\IS02<67/HO\>AJ[D,P=*JW0
MRPNX#N-G1*B\1'2U*+E#DM-P>&R-!QN6 )0]/99P7%)A#;ZP4$4%7P?MA>6Y
M]NQO'=-XZFJSDA9&43 +%O0TT')CX;M KMMWV'3)LW #AGA^"H1 Y^(-<!X)
MA/%L!&"P )RW%BA*3L8@F.'SA58S\?(#4&.2='^: 6T%%H5.9X+:2(0=O"":
M 1L@*I"LRQHI9KMDED=1EH99Q$D2L#P!=@WPP)12N:[8ZC;D5O@-A-H9)+.9
MM,H3^XXLBX(K?$"A3<%Y(5][1I80++5#Y.U(O&X4H':GCO=O4;-/"5;:9ZKV
M.?:6SU[SPH9/5'*NAE,@)^^'Q/ GLEC)M8,7?Z^PV9,U[RV7>V.9O *= =EY
MDM!,EFR1=6W(A,B)$HDP2(DNLJNF+$SVWOG+02H6D=P;M!"0R1[(&3#%95/4
MNF(%(@BP,.H,[1BJZXT"P=UX2OUK Z.31V#@59*\E9A;ILH4-3?P<@G<%F7%
MF;+H4_!:EA4S(,PPU7PDSE ,!38#$XJK,;,9LHF68>#Z02L!%MJ4?CV>C\)W
MK0$!U,IRKEKQN>M/0TT$I%FO"$1NVBH34BQ@(P$<&ZP5I59F)7&9_D&%O$^3
M3P70<F;E4K6Z$.W@$MTEL'W748Q@8:9XKX&1_H1#S$!T0($:>5(!P,W7L-&@
MS@&!8:T )0;^6K#_$.C@*R1'(/_=E#>VF%=OK.E5@/TPV.]R"J7"_D4K[+_U
MPOY$/&MT4:-A58H7*I.YXCC)EGR^_( J/)ZN.[45/>;=,%N^V&7XVVGL8[VR
M!)*?=PU_J#1.E2K%-"#EII5*161$-"5M#I@E(F_.R)LR_DU+T(",BJDJ[$UT
M? -Y!S.[.&OBU,1O@HN #'N*P@:O$]@%2E7%P@3:^<7%0CL?0<"L,NC>"('*
MK)3UWA+/T'59FDMF_KQ 4->LNM2F<0!)\I.@<FXU((\NR$^";\NYU<#"22EK
M563X?&L<!55_4X.O<7)Q1J:"20)\5V@, ZE+DDT+.>.&TNU5V)XM]L1I/XE3
M1.E<%>063(]5E&3+1#0-5NV9-4L0X:=H93&69$<RA 5G@[?'P( (]V@QQX-"
MFFT8O!6IV>H%CP2YDHSS3'W8"AV=HXI.EU4PF3F(R6)A'(BC0&[<Z6[3-][;
ML'^;"KT.1=17E!=KT483YG2:!C(%9PX+OYW0.C8!DOE^E%K[VB ^H'G%&@01
MT.P_GTBBR;#K%2)0>T].5QG(9>55(]JI]Z59@6H%7Y^#+H+N&;Q:80",C\E:
MLT$*-GM*EODI/4;4$) MUQG9YV0)JZMUYC[J,2(OP0QV#[$<N$4&\%=HCO/N
M8M1O> 9^8P/V^,T>6NW>AX<W'23#ID(KG%.[%;TI8#+%M>N:5N/W(.+%1D"[
M-\-BW!D:51,;:@T:);!"*UQ%>$A,5==LYE.@LQHZ+NP W++5>D/C.N(#LFDV
MJF(X$@71X=]A>KJ^7EAT%S& [P#U&BJ*ZR>7#,XJ%73C22=FWF%OGIO#['7E
MW7# [60S;]7KS4FC]P^T\579B>Z+:FOOMN]9WCZRO& 6VQ2A'?$V[;QAA"3J
MFDC QV7G#59'A#B0K9;Q..\[;;TM0&@*9*(8>0-?DAC:C9X ]DP,\#YP855T
MKWJGPAH)=%/J7_DL,O%BG[!?!] 0D-?ETO.@I2F9<>9\LB/E0 ][N:9C"W,!
M]A^(AS?EA44  <QP!EW/SH65ES#:*ZM 0'Z[&+T8#;P[)U&J/^+/^5G%C!"R
M-_V6#\Y[SWA'O#T0Z9#;THC>_4DNJ],7&PK&ZSJP-4??RS85LSSJ^NWG!\0Y
MAPNS(BK)9!GH>"/)UX]XLO;N-F3"3C2TVP%M$B?=MA$1]GE6@V8WPR/A(_2!
MSV$60 FJ(*HHK&GA@)>PL4U77"%_V.XH?PZ^L+V)KB?,=])$=]$14";BA]9U
M3X(-F@/PH+YER0T3FX.&4O!Y;!.DU^)-ZHBMQ3D>D2]V#OY_"^W/Q1XO]_8%
M%CP''.+%ZM*54GV(.(15.^#\*%T XD=;UI81<D<<2WO>^I"J/5[N?B!EHCWZ
MF%>00)9 ;].85TI;C))?BWR@L8,6"[*M#U5*XU'3T'9V,9/<5;O4# ,R^,+D
MW@CE0/Q!^ZZ/-4T-O-Z631%6A3,Q2 AU66L*]#6K\E);4Z+^.DC\S3X&*_EF
M"%WM!:@O<":WDY+Z0) O@B:OT>\#YZ[(@0\HMJ&A]F"*2](6MV-R0TSAH'/T
MHA6-]"QO($/=F!5/Y!VH7!6J#=/EP(1RG83UTLL9)KN@76X[1L*0Q\5GDJ+@
M=BEU0:,NE<0IM5DF2PVJZ11-8VG<1VM=Z\20)UZPQV.,XLM\60M,_D.%SNM7
M&-D7)TLA$3YP/)WL=)WJV*!R734 _F4U)M2@*GTXAAT>CWMR\7L/&KO-;-E/
MH;.'^PFV+Y/KVL=>?BW':&]9;F*CY>S.0?2Q;'%3ST@7\I(EW3:2'474C#RK
MQ$.]!%V2WU" ?@8,L"@HV,%SNCPU#E-0Y%K5(M<N0_:C\EZ)V^/EWC[6;BAQ
M"VE+2J?:0,N.!]WY_"P)./<!,U1JVV1LINXZC#&O0E,M#W)=JEQ+3EGIJ'%\
M3MJJ4-'K0-YZ]"=[MP9_L/V<"\IBHL=9%8-Q@Q<:3Y./ DAL[M$FTGDC]5!W
MPYI)F$,72:_Y]0=Y_P^R5UN<=P^E"66MGRA&GF_'+;0FD$XD2]2&6M>@-7"P
MT(.)1:FJ>BNJ @][#!#2X2QS58-BJRP6&X'0H8:I9638V30;82WH7QMI:XY3
M$FDI#ET"^3*U9)JB7:)4<N %9[""7F=*Q K4ZMB;2(FF6*JCFY2,@'.Q]A:G
M7Y<S*R,1$A7,I*1, D/!F7DW)"/Q^8)"2LD.EKUS= ^3ZI*@B[R->LK5DK(8
M<#:UA5GH-HR'H1;2@BDH1O^+29AVFROU1<6\XY<U;MAWFP]QZFNFG@#]-%'-
M(H5<&(J<"8$\$M!P,S.9\NDH>P+!AZY&"=RC'A:(P3$?O@O2;H@) (6":;K+
M'I)+M_1U+G O&ZY0L6OB&(!#-2W"!+LIPC+/+?.T]PJS'+RKG78';0%A.FRX
MH+P'GD24WS***V/WN?:EJ9;X%_Q#7]@!&40"=.+V\M<^+'>7IG3[-/L<ID8A
MD4B@!EN$+J&*.Y/>070I"(G+3G@C2DE(^=MB@*V4I:ED"Y->6/L*R!E[BQK'
M3E7MO(6;E9,*;?0E4@XJ26/XXS0DQ0H">;U4(_'R4A8-$1@@"!B*Z=#:)K#$
M#<>3B*/Q$'^%D@?,E<),.'0/OMS,00#DM*-4W,29)K:\&=7"(03PH7ETF:V(
MW=1I'\,N$59(I7B&=3=&!H@CLALDYAC4!NNX-1FO%_+V>+FW3S!V)I)L<+L*
M#JC,%F@*H*B'*Y,E=\;-=@K3$)&)P43;DH736 S&@MH'LF*M.)AMA9GM\&\X
M>AS&JUUE'-5[0I9:%'"6D_1+ ] %N+8"92L\LJCCLU$Q\JE52&%=L%YBOM/U
M,%8JH(126.>LB258>D]=?Y3W\2@GY2SX?&TE&&S']=5)&O>FR@3'\1+#B;9C
M_N!6)JFJCJ^,% 1Z^((O:;+I#APZ&*%;IF)&R==8^0.]7E<4X=D(#7T!RB/&
MA;;!GJ\:BUP:OP<*A@H6T<U(]%@B);6+DM*F8LXZRN11%MDL:-S5>./\=A0J
M"L"!87=&%Y Z/!+/0E8*@C;(+34**T%X62E/'E.5+W$KUI3?#:1QK57A\UG\
MAE9-[3C/%.2C(>:A8Q:,=C&RV*4K!UKKJ)[)E>#SV1N,5C#W=O^O9 :#9/XS
MY</J2$[J5G?)%D!\54G5VYTSH'G6P=K'\A> %L,OVO3!Z+I-B7=!D7M4*XNT
M*3.;#>>24 C6QR8&9B2LBC&X^"V%U8+7\-BOC;8*5_"5EDWI:>Z_.[RT#2__
MH5.S^BW;=  )SV(8$9SW%VV22Q\WVB/\_@L9).#O+*\>^%VL[A%L==WXGRNR
MU3@_6W%N>'N(.&N/$]FB3#[K!.-UBG7%5$\6+"C/LU>]^Z.TCT?I9Q1Q0-8+
M$MZN?@>^0$#,I(6/E]MI29>8;;L[@P@_AL47DGBWH!;/0>P1*M=U&N^-M>DX
MG\C"V:$9X!GT\72I&R(I3T>EIB.[ SH <T;73$:269NK'!HW9%C; :UB'6D.
M5']0(Q3J]VBSTUX^E,4,_Q\H!%D*SBD/ZV=QCN=[0&*P )U&9P.4Z.!1@*,J
M@3HYLYYRP%_:.*+]O@CU9LDR@,0'-)@J%-5C2;#7]GOJL7_4XVPC =.[':W*
MN (FEX$/7=<DE[?T^,^J;WLNN7R[=SN2!RX>&^^I)2T_Y=>QP)FKN\>\RZ9;
MSASJIB!OMC(GUZ,L^K/U>X^^V_<@UJ/]!%L?Q-H?HSO!IW9D3V%-+ &R'&7-
M5EPB#)T]( NCD3@I(]J6T:0Z!3L+X,A0(BRSFDS+R K9RBDI\"<9@E(Q+E4-
M#'.CQ@);)F$U\=,8/-AYWRNRG#\?'KN"I;:1NG()T.?Y2;?PSR&7)K$3MG,A
MF@JD3U^VN@\*[,7.NV3P?,?RYO-8NYTT,_%*EZ! H4?CKUB"%C^TIRV^;PJQ
M<GT9QO8S0C8U.1H='1W]\11=VH5<3V:%^O#;R_5S'J) CE##M[ $F*U/:5%#
MC9Z2"1K#\-6=(%C"A97.ZP7\/CS6Y1XSD_/U$I TPDA3G.5PBD6D/^G%CX!K
M"PKD1IV-IX_B_B4;UYW!OH GT0F!5VF*K=IHCH!&&C1NQ!8)@ZOZ(PQ\8/UR
MR@X[?.N9P68-\..%!L9%P9%J-E/L)?U; [K?X:.!CW2-]<*G7-BYC;$Z'(NU
MDI:<<Z'QYH":S3"A(.Y'4;JD&6(]LAP4QX6NTD*DL?9EF]_-$9WH["2K3?"X
M@&ZL:OTO_+EI+TM+CHX *!H]T4;\8CCX,K2,"SYAUJFQX+:RR+0!F/\ 6"4-
M)V!);XCPG0W$>31[XRQ>MU4/92U>2$MEG%Z7<ZQ\IR@.I=.9#K#-_[NGD3V-
M[&GDEX^0;2@9;M90Q!=&P:/9VU< )N/O7)5FV>E1EL=HDPIS@LHAI2C$R)3O
MG5(Y1JK=XP%B2[7:ZJHP.H_&],3&/T*/&&4V;0?*;=F@N5*^<&UT+]^N*;T)
M4R(BF1E03S0,IX%[7'P"5[*00+HPOB6$3(R [G!8+)O]0GP\M4*FV V,^2C-
M*AKVV!='U5QYAFT['ZEAW[PA,?&\A>"8C<B96NF2PR^,ID8WOD=1TK1QIJ<4
M!;C1-F>SK4YT3;C?I* [",J=)*K7[KK;$]6>J/Z[B>I/I3A75<U2X^$!"X,#
MWWZ6;#3?'8]CHK&LAW!FASXSYONSBS?WA%N@:48[UW"[,JZ_3 '%:&GA[.<T
MC@"-0!AVYD!]%7B!1@!:TU@<HPX=-.-(O8C54X.>&MP$-7B)'AW*B\': [$H
M%W#SPJ=M(A4@*4F2FH>2T;PP4XHU-OAB4(\Z&80^N@?$G3.G95KC&NMGA^@!
M[[O<748(DWHTQ2S(3FQO4@I<%C#[TK?'-B >%4M\AT@1RDIMT.RN974]IM[.
MRZ;?2JY9F(,%*,EMN:EF^<JTFC''/]FE;UO1!9D$L+!+-RTZAFM)YH_EYS&K
MDT6Q3X'K;]/&E%0\'#U\^.B."D\]N>S)Y9Z IQ/) 0>_E9^.QD%^BOZNG"C(
M@.D(1JE?RH*-1Z@! 27"!$W*]<8'8+3O#AZ,3H+ -1),3+"M!25?.GZN<9+;
MT)$3[@,5?P&E^+NCT<,HJ_G<1DJ2%CY'/LUKQ^Q.SN)D&J<LJM,DPZW03<=*
MY71-E$QEOLELJ#CJ)!/H.69!([4]H^*-X@4V.RV<>*-S;+P',N*+-_<&,0 %
M]="LH'K;FI58S*7WO0LH9467J.TRJ=Q(*J#ZD1IU64P[(1HL:S\#1TGT(=J.
MH>N7YTV37,6#0E5;%?MWK'Q^HI>\IZ,]';T9.NI5Q214P)>ZPD#U0M7>TA<H
M#Z>O8PU\3'-BPC9.Z-&+-X'**>O+.Y#14&:^MB5'$4S57'Z46(ZYX1K&W'*\
MWG='QZ-''3)K:NH'C504L\LP<KU3Y<(JK!#A? 1=]MY7ZZ!%^=P^IE_="B3X
M)XJ77Z>/H:_W^F]P]'_S]+DI9Z##(1M_CE$PR A_5E/ SOI.P;&/#[EA(MSZ
M1!%EKG R;[JG@S>ZC1H)#SY#+?KOQL'C[P?)D#L:P6!J<-(YAA5PZM^&ZG%$
MYRR@\XK1F0H;-ES/C9G&?[CHGQ9-A6D" U"?L<H AUE+(.V8GV#*(=85 F:
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MC?/$&*K-5:R,S;'O$Y;_:M>:=(AK.TJ$FZ&)[O:=D'"P?2>VA=]QBRM<;]_
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MKS.3E'WNQ-$>K>X<6KT..6?O8L[9_N%83^+N'BY>M_S"I<YA):#@W#\'9KH
M71(64M[_FUF4XB]P96I2S.C!^FDY+'8.VMQ;;Y[M 7AM 'Y_>'!X3SP<CX<'
M)^/#'H#7!N 2Q9;_VLY[N&G5_PYMW1=5=GHY[<X?H?.%LE:+\TI)>X?0>%_
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M,#(Q,#DS,"YH=&U02P$"% ,4    " "J@$531U"E[Q4#  #&"0  $0
M        @ $&&0  8VQX="TR,#(Q,#DS,"YX<V102P$"% ,4    " "J@$53
M5O8R^<4&  !32   %0              @ %*'   8VQX="TR,#(Q,#DS,%]L
M86(N>&UL4$L! A0#%     @ JH!%4S#(5V6M!   OBL  !4
M ( !0B,  &-L>'0M,C R,3 Y,S!?<')E+GAM;%!+ 0(4 Q0    ( *J 15.&
MQ5DG(20   D/ 0 /              "  2(H  !C;'AT+65X.3E?,2YH=&U0
52P4&      4 !0!! 0  <$P

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
